PharmEasy's valuation declines by 90% after raising $216 million

Mumbai-based online pharmacy startup PharmEasy has reportedly raised $216 million or approximately Rs 1,804 crore in a recent funding round, but at a significantly reduced valuation. According to reports, The valuation of PharmEasy has seen a drastic cut to $710 million, down from its previous valuation of $5.6 billion in 2021, reflecting a 90% decrease.